Slovenia vs Türkiye: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Slovenia
0.0%
in 2024
Türkiye
0.0%
in 2024
Slovenia rank
167th
Türkiye rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Slovenia
- Türkiye
How they compare
Slovenia currently reports 0.0% against 0.0% in Türkiye, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Slovenia ahead.
Slovenia ranks 167th and Türkiye ranks 167th of 246 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Slovenia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.1% | Slovenia |
| 2020s | 0.1% | 0.1% | 0.0% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Slovenia or Türkiye?
- Slovenia, at 0.0% against 0.0% in Türkiye as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Slovenia and Türkiye?
- 0.0%, with Slovenia ahead.
- How many years of comparable data are there for Slovenia and Türkiye?
- 10 years are reported by both, from 2015 to 2024.
- How do Slovenia and Türkiye rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Slovenia ranks 167th and Türkiye ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.